Annotation Detail
Information
- Associated Genes
- NRG1
- Associated Variants
-
NRG1 EXPRESSION
NRG1 EXPRESSION - Associated Disease
- lung non-small cell carcinoma
- Source Database
- CIViC Evidence
- Description
- In-vivo studies of residual NSCLC tumors (xenografts of 5 cell lines) after chemotherapy found increased EGFR-family signaling and NRG1 expression. NRG1 inhibition (YW538.24.71 antibody) led to decreased tumor growth and enhanced magnitude and response to chemotherapy.
- Variant Origin
- N/A
- Variant Origin
- N/A
- Evidence URL
- https://civic.genome.wustl.edu/links/evidence_items/779
- Gene URL
- https://civic.genome.wustl.edu/links/genes/2593
- Variant URL
- https://civic.genome.wustl.edu/links/variants/314
- Rating
- 3
- Evidence Type
- Predictive
- Disease
- Lung Non-small Cell Carcinoma
- Evidence Direction
- Supports
- Drug
- Cisplatin,Gemcitabine,Carboplatin,Paclitaxel
- Evidence Level
- D
- Clinical Significance
- Sensitivity/Response
- Pubmed
- 23390248
Drugs
Drug Name | Sensitivity | Supported |
---|---|---|
Carboplatin | Sensitivity | true |
Cisplatin | Sensitivity | true |
Gemcitabine | Sensitivity | true |
Paclitaxel | Sensitivity | true |